| 9000683 |
25-hydroxy Vitamin D3
New |
|
19356-17-3 |
≥98%
|
|
|
2012-01-12
|
69.944444444444
|
25-hydroxy-vitamin-d3
|
RO 8-8892; Rovimix Hy-D; U 32070E; 25-hydroxy Cholecalciferol
|
25631-40-7 calcidiol calcifediol calderol dedrogyl didrogyl hidroferol Hy-D Ro 8-8892 Rovimix Hy-D U 32070E U-32070E U32070E 25-OH cholecalciferol 25-OH vitamin D3 25-hydroxyvitamin D3 phosphorus metabolism neuromuscular inflammatory intermediates receptors livers kidneys plasma serum |
69.944444444444
|
| 10007121 |
2-cyano-Pyrimidine
|
|
14080-23-0 |
>98%
|
|
|
2006-06-19
|
1.787375690607
|
2-cyano-pyrimidine
|
|
Bridge organics inhibits inhibition inhibitors cathepsin K osteoporosis bone resorption osteoclasts lysosomes cysteine proteases |
1.787375690607
|
| 10010255 |
5-(galactosylhydroxy)-L-Lysine
|
|
32448-36-5 |
≥95%
|
|
|
2008-09-22
|
0.150828729282
|
5-galactosylhydroxy-l-lysine
|
|
bones resorption galactosylhydroxylysine glycoslylation hydroxylation type 1 collagen density markers |
0.150828729282
|
| 19023 |
AH 23848 (calcium salt, hydrate)
|
|
- |
≥90%
|
|
|
2009-02-26
|
56.043558011050
|
ah-23848-calcium-salt-hydrate
|
|
AH23848B AH 23848 TXBs thromboxane PGEs PGE2 receptors prostanoids TPs EP4 antagonist blockers inhibitors inhibits inhibition TXA2 platelets smooth muscle bronchial U-46619 U46619 fibroblasts cancers metastasis 81739-45-9 AH-23848 |
56.043558011050
|
| 13642 |
Alendronate (sodium hydrate)
|
|
121268-17-5 |
≥95%
|
|
|
2010-08-02
|
30.909539594843
|
alendronate-sodium-hydrate
|
MK-217; G-704650; Fosamax; Adronat
|
Bisphosphonates bones resorption osteoclasts osteoblasts osteoporosis bone mineral density fractures metabolic diseases vertebral fractures increase decreases 4-Amino-1-Hydroxybutylidene 1,1-Biphosphonate
4 Amino 1 Hydroxybutylidene 1,1 Biphosphonate
Bisphosphonate Aminohydroxybutane
Alendronate Monosodium Trihydrate
Aminohydroxybutane Bisphosphonate
Sodium Alendronate
Alendronate Sodium
Alendronate Fosamax MK-217 MK 217 MK217 |
30.909539594843
|
| 700550 |
Calcium Assay Kit
|
|
- |
|
|
|
2011-05-12
|
161.036813996317
|
calcium-assay-kit
|
|
kits assays measures measurements Ca Ca2+ minerals skin cells hair nails urination sweat feces skeletal systems tissues bones teeth mass neurological endocrine cardiovascular digestive metabolic pulmonary heart cancers diseases homogenates lysates o-Cresolphthalein-calcium |
161.036813996317
|
| 16835 |
CAY10580
Exclusive |
|
64054-40-6 |
≥96%
|
|
✓ |
2009-03-16
|
77.547532228361
|
cay10580
|
|
PGEs PGE2 receptors inhibitors inhibits inhibition antagonist blockers EP4 cAMPs bones fromation resorption cancers atherosclerosis |
77.547532228361
|
| 13281 |
CAY10598
Exclusive |
|
346673-06-1 |
≥98%
|
|
✓ |
2010-05-07
|
73.670928176795
|
cay10598
|
|
Prostaglandins E2 PGE2 receptors EP4 bone formation cancers atherosclerosis agonists EP1 EP2 EP3 DP FP IP TP neuroprotection renal dysfunction inflammation neuro-protection |
73.670928176795
|
| 10012583 |
cis-ACCP
|
|
777075-44-2 |
≥95%
|
|
|
2009-02-10
|
0E-12
|
cis-accp
|
|
MMP2 MMPs MMP 2 MMP9 MMP-9 9 tumors cancers extracellular matrix type IV collagen cell migration artritis osteoprosis |
0E-12
|
| 580200 |
CTRP3 (human) EIA Kit
New |
|
- |
|
|
|
2012-01-20
|
7.292605184870
|
ctrp3-human-eia-kit
|
Complement C1q TNF-related Protein 3
|
kits assays EIAs ELISAs enzymes immunoassays measures measurements complements C1q TNF-related tumors necrosis factor-relateds proteins 3 secreted glycoproteins morphogenesis metabolisms cells functions cellular paralog adiponectins adipocytes leukocytes blood chondrogenic differentiations bone cartilage angiogenesis ERF1/2 signaling signalling adipokines mice mouse humans recombinants suppresses suppression hepatic livers glucose sugar C6H12O6 output inhibition inhibits inhibitors gluconeogenesis levels normal ob/ob obese/obese antagonizes lipopolysaccharides LPS toll-like receptors 4 TLR4 competitive serums plasmas cultures supernatants |
7.292605184870
|
| 10112 |
(±)-Enterolactone
|
|
78473-71-9 |
≥95%
|
|
|
|
6.983867403315
|
-enterolactone
|
HPMF
|
lignans plants antioxidants cancer oxidative injury stress enterobacterial |
6.983867403315
|
| 500520 |
Enterolactone EIA Kit
|
|
- |
|
|
|
2005-03-15
|
122.405021485574
|
enterolactone-eia-kit
|
|
solid plates steroids measures kits eias enzyme immunoassays ELISAs endocrinology assays enterolactones mammalian lignans phytoestrogens estrogen-like diphenols diphenolics intestinal intestines bacterias plant matairesinol secoisolariciresinol diets dietary acute coronary hormone-dependent cancers osteoporosis serums plasmas fiber |
122.405021485574
|
| 600410 |
EP4 Receptor (rat) STEP Plate Assay Kit (cAMP method)
|
|
- |
|
|
|
2011-06-28
|
6.746537753222
|
ep4-receptor-rat-step-plate-assay-kit-camp-method
|
|
cell-based assays cells CBAs kits measures measurements prostaglandins E2 PGE2 prostanoids G protein-coupled receptors proteins GPCRs EP1 EP2 EP3 signals transductions mechanisms tissues localizations regulation expression intestines lungs kidneys thymus uterus brains cyclics AMP adenosines monophosphates pathways phosphatidylinositols 3-kinases G1 smooth muscles relaxation gastric secretions intestinal epithelial transportation adrenal aldosterone uterine immunity inflammation human colon cancers colorectal carcinogenesis in vivo neuroprotective excitotoxic injury injuries agonists antagonists therapeutics diseases surface transfections and expression protocols transient technology technologies University of Michigan UM U of M Originus, Inc. USPT United States patents 6897067 6902933 7056741 DNA deoxyribonucleic recombinant proteins cells receptor-mediated endocytosis solution-phase efficiency multiple plasmids constructs intracellular |
6.746537753222
|
| 10007806 |
Epoxomicin
|
|
134381-21-8 |
≥98%
|
|
|
2008-12-09
|
46.601679558011
|
epoxomicin
|
BU 4061T
|
inhibitors inhibits inhibition proteins degradation 20S proteasomes antitumors bones formation Parkinsons diseases anti-tumors |
46.601679558011
|
| 13624 |
Icariin
|
|
489-32-7 |
≥97%
|
|
|
2010-02-11
|
1.738950276242
|
icariin
|
|
PDE5 inhibitors flavonoids differentiation cancers proliferation flavonols E brevicornum horny goat weed BMP2 ED erectile dysfunction 2-Phenyl-Benzopyrans
2 Phenyl Benzopyrans
2-Phenyl-Chromenes
2 Phenyl Chromenes
Bioflavonoids Flavonoids |
1.738950276242
|
| 10007712 |
L-902,688
Exclusive |
|
634193-54-7 |
≥98%
|
|
✓ |
2010-05-07
|
44.592225730070
|
l-902-688
|
|
PGE2 bones growth EP4 agonists hyperalgesia vasodialation |
44.592225730070
|
| 10007692 |
Licofelone
|
|
156897-06-2 |
≥98%
|
|
|
2006-04-03
|
35.333449969306
|
licofelone
|
ML 3000
|
inibits inhibitors inhibition lipoxygenases LOX cyclooxygenases COX osteoarthritic OA synovial explants arachidonic acids AA shunting interleukins 1.beta. IL-1b synthesis prostaglandins PGE2 leukotrienes LTB4 lipoxins LPS cells non-steroidal anti-inflammatory drugs NSAIDS gastric mucosa parietal acid-secretory mechanisms ML3000 |
35.333449969306
|
| 13058 |
N-Oleoyl-L-Serine
|
|
- |
≥98%
|
|
|
2008-10-17
|
2.381270718232
|
n-oleoyl-l-serine
|
|
lipids bones endogenous anabolic activity activities formation resorption cannabinoids cbs synthetic |
2.381270718232
|
| 9000395 |
Oxy-16
Exclusive |
|
596-94-1 |
>95%
|
|
✓ |
2010-09-15
|
36.048853591160
|
oxy-16
|
20(R),22(R)-dihydroxy Cholesterol
|
oxysterols sterols hedgehogs bone formations cardiovascular diseases inflammation macrophage antagonist oxy16 16 26649-05-8 26622-99-1 4005-81-6 15234-55-6 Hhs signalling signaling oxy 16 Besins-Iscovesco Brand of Androstanolone
Besins Iscovesco Brand of Androstanolone
Berenguer Infale Brand of Androstanolone
beta-Hydroxy-5 beta-Androstan-3-One, 17
17 beta-Hydroxy-5 beta-Androstan-3-One
17 beta Hydroxy 5 beta Androstan 3 One
17beta-Hydroxy-5alpha-Androstan-3-One
17beta Hydroxy 5alpha Androstan 3 One
Cuxson Brand of Androstanolone
5-alpha Dihydrotestosterone
5 alpha-Dihydrotestosterone
5 alpha Dihydrotestosterone
5 beta-Dihydrotestosterone
5 beta Dihydrotestosterone
Dihydroepitestosterone
Steroids, Catatoxic
Dihydrotestosterone
Catatoxic Steroids Diflucortolone Androstanolone Pregnatrienes Norpregnenes Azasteroids 5-alpha-DHT 5 alpha DHT Ro 10-7614 Ro 10 7614 Stanolone Ro 107614 Andractim Anaprotin Steroids Cholenes Gelovit |
36.048853591160
|
| 512031 |
Prostaglandin D2 EIA Kit
|
|
- |
|
|
|
2010-07-19
|
268.101938305709
|
prostaglandin-d2-eia-kit
|
PGD2 ELISA Kit
|
PGD2 prostaglandins measures kits eias enzyme immunoassays ELISAs measurements brains glutathione-independent lipocalin-type synthases L-PGDS cerebrospinal fluid CSF physiologic sleep rats humans mast cells leukocytes intracellular myeloid-type glutathione-dependent vascular 11β-PGF2α eicosanoids cultures lysates biosynthesis serum proteins albumin media medium methoximine derivatives PGD2-MOX competitive enzymatic reactions |
268.101938305709
|
| 512041 |
Prostaglandin D2 Express EIA Kit
|
|
- |
|
|
|
2010-07-19
|
125.652167445813
|
prostaglandin-d2-express-eia-kit
|
PGD2 Express ELISA Kit
|
PGD2 prostaglandins measures kits eias enzyme immunoassays ELISAs measurements brains glutathione-independent lipocalin-type synthases L-PGDS cerebrospinal fluid CSF physiologic sleep rats humans mast cells leukocytes intracellular myeloid-type glutathione-dependent vascular 11β-PGF2α eicosanoids cultures lysates biosynthesis serum proteins albumin media medium methoximine derivatives PGD2-MOX competitive enzymatic reactions |
125.652167445813
|
| 10009634 |
Purmorphamine
|
|
483367-10-8 |
>98%
|
|
|
2007-07-19
|
100.131752170481
|
purmorphamine
|
|
stem cells differentiation osteoblasts osteogenesis osteoporosis bone smoothened hedgehog progenitor cells expression signalling pathways signaling transmembrane agonists receptors |
100.131752170481
|
| 10011620 |
Raloxifene (hydrochloride)
|
|
82640-04-8 |
≥98%
|
|
|
2009-01-07
|
5.901491712706
|
raloxifene-hydrochloride
|
Evista; LY156758; Keoxifene (hydrochloride)
|
breasts cancers osteoporosis SERM estrogen evista bone remodeling formation IL-6 IL6 25-OH vitamin D parathyroid hormones cardiovascular protection |
5.901491712706
|
| 10011132 |
Rolipram
|
|
61413-54-5 |
≥98%
|
|
|
2008-12-16
|
11.821048563680
|
rolipram
|
ZK 62711; SB 95952
|
inhibits inhibitor inhibition phosphodiesterase PDE4 cAMP inflammation leukocyte LPS TNF monocytes C5a LTC4 eosinophil neurons bones loss |
11.821048563680
|
| 10822 |
SMAD1/5/8/9 Polyclonal Antibody
|
|
- |
|
|
|
2011-04-14
|
1.483314917126
|
smad1-5-8-9-polyclonal-antibody
|
|
WBs western blots immunoblotting SMADs 1 5 8 9 SMAD-1-5-8-9 1/5/8/9 antibodies serum 1,5,8,9 |
1.483314917126
|
| 10821 |
SMAD1/5/8/9 Polyclonal Antiserum
|
|
- |
|
|
|
2011-03-31
|
0.422541436464
|
smad1-5-8-9-polyclonal-antiserum
|
|
WBs western blots immunoblotting SMADs 1 5 8 9 SMAD-1-5-8-9 1/5/8/9 antibodies serum |
0.422541436464
|
| 10839 |
SMAD6 Polyclonal Antibody
|
|
- |
|
|
|
2011-05-02
|
0.422541436464
|
smad6-polyclonal-antibody
|
|
WBs western blots immunoblotting SMADs MAD SMAD-6 SMAD 6 antibodies serum IHC immunohistochemistry TGF-β TGFβ Tcells intracellular proteins signaling serine threonine apoptosis bones cancers genes signal transduction |
0.422541436464
|
| 10006321 |
Tibolone
|
|
5630-53-5 |
>98%
|
|
|
2005-01-25
|
49.142074334505
|
tibolone
|
Liviella; Livial
|
steroids estrogens estradiols osteoporosis postmenopausal proestrogenic 3.alpha.-hydroxy 3a-hydroxy 3.beta.-hydroxy 3b-hydroxy androgenic climacteric bones symptoms menopause transition effects mass endocrinology |
49.142074334505
|
| 10009083 |
Trimidox
Exclusive |
|
95933-74-7 |
>98%
|
|
✓ |
2008-02-13
|
5.938674033149
|
trimidox
|
VF 233
|
apoptosis ribonucleotide reductases cells cycles cancers dNTP HIV caspase DNA synthesis chemotherapy dGTP HL-60 |
5.938674033149
|
| 16837 |
β-Carotene
|
|
7235-40-7 |
≥95%
|
|
|
2010-08-20
|
10.558316944599
|
-carotene
|
NSC 62794; Provitamin A; Food Orange 5; KPMK; Solatene; Provatene; Lucarotin
|
vitamins A antioxidant retinol retinoic acids vision bone growth receptors RAR cell differentiation 116-32-5 31797-85-0 lucaratin lurotin provatenol serlabo βCarotene β Carotene b-carotene carotaben b bcarotene retinol |
10.558316944599
|